Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    SLCO1B3
Show Display Options
Rank Status Study
1 Completed Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist®
Conditions: Pharmacokinetics;   MRI;   Liver;   Drug Transporter;   Gd-EOB-DTPA
Interventions: Drug: Primovist® 0,25 mmol/ml solution for injection;   Device: MRI
2 Completed Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8
Condition: Gastrointestinal Hormones
Interventions: Dietary Supplement: mixed meal;   Drug: Rifampin
3 Recruiting Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Eovist
4 Recruiting Role of SNP and DIGOXIN Response in Atrial Fibrillation Patients
Condition: Atrial Fibrillation
Intervention: Drug: Digoxin
5 Completed Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate
Conditions: Healthy Volunteers;   Pharmacokinetics;   Drug Interaction
Interventions: Drug: Rosuvastatin;   Drug: BAY1841788 (ODM-201)
6 Recruiting Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Condition: Pharmacogenetic Study
Intervention: Drug: Abiraterone Acetate
7 Completed A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin
Condition: Asthma
Interventions: Drug: Rosuvastatin 10 mg;   Drug: GSK2190915 30mg;   Drug: GSK2190915 100mg

Indicates status has not been verified in more than two years